s. korea to double antiviral drug reserve , page-10

Hi CPG,

Just remember we are now basically back to when Relenza was first launched and when it hit the $9 mark.

It was only Tamiflu that basically killed it off and gained the market share back then.

Now Tamiflu is on the way out and Relenza is again taking back Market share at an increasing rate.

The last Qtr sales where more Relenza was bought then Tamiflu shows us that we have already gained back the largest Market share.

This will only keep growing imho.

The swine flu will speed all of this up even more.

And now we have also LANI waiting in the wings, so we can probably say the Biota is even stronger now then it was back in those early days when it got first on the market.

Ofcourse we have also more products in the pipeline at various stages in the clinic.

So what kind of a share price should we then put on Biota today???

Its everyone guess but I think Biota has got some very strong legs and will do the walking.

jojo